Log in or Sign up for Free to view tailored content for your specialty!
Irritable Bowel Syndrome News
‘Extremely low’ likelihood of missed GI diagnosis after using Rome IV criteria for IBS
A diagnosis of irritable bowel syndrome based on Rome IV criteria was “safe and durable,” with only 1% of patients diagnosed with a different gastrointestinal disease after rereferral and reinvestigation for ongoing IBS symptoms.
Expert dietitians play ‘powerful role’ in the care of GI patients
In my more than 30-year career as a registered dietitian in gastroenterology, it has been exciting to see the role of dietitians in gastrointestinal conditions become validated and expanded upon, most markedly over the past 10 years.
Log in or Sign up for Free to view tailored content for your specialty!
Low-FODMAP diet for IBS ‘not intuitive,’ must be taught by a GI dietitian
Irritable bowel syndrome is a dysfunction in the communication pathway between the gut and the brain, which contributes to symptoms such as gas, bloating, abdominal pain, diarrhea, constipation and mixed bowel habits.
Tacrolimus shows promise in treatment of dermatologic conditions with risk factors
Compared with the systemic calcineurin inhibitor standard cyclosporine, tacrolimus shows promise for numerous dermatologic conditions, whereas the literature on voclosporin is limited, according to a study.
Healio seeks nominees for Disruptive Innovators Awards in gastroenterology
Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.
Court upholds Bausch Health victory in Xifaxan fight; Norwich generic blocked until 2029
A U.S. District Court judge in Delaware has denied Norwich Pharmaceuticals’ motion to modify the court’s final judgment, which blocks the FDA from approving their 550 mg rifaximin generic until Oct. 2, 2029.
Gut-directed hypnotherapy improves abdominal pain, stool consistency in IBS
CHICAGO — Digital gut-directed hypnotherapy resulted in greater improvement in abdominal pain and stool symptoms in patients with irritable bowel syndrome compared with digital muscle relaxation, according to research.
VIDEO: Treating comorbid conditions important in IBS-C, CIC
Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.
VIDEO: Health disparities in IBS-C, CIC
Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.
VIDEO: Vibrating capsule shows promise in CIC
Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read